Terese Sybor
Family · Clarksville, MDNPI 1225548308
Payments from drug & device makers
Across 20 payments — averaging $21.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$153
- Alkermes, Inc.$36
- Esperion Therapeutics, Inc.$29
- Bristol Myers Squibb$26
- Teva Pharmaceuticals USA, Inc.$24
- Mayne Pharma Commercial LLC$23
- plus $133 from 7 others
What the payments were for
- Food & beverage$423100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $153 |
| Alkermes, Inc. | 2 | $36 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| Bristol Myers Squibb | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| IBSA Pharma Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Sanofi | 1 | $19 |
| Gilead | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $14 |
How this compares
$423 in reported general payments places this provider in the 55th percentile of 2,843 family providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 17 | $613 |
| Amlodipine Besylate | 33 | $459 |
| Celecoxib | 19 | $247 |
| Levothyroxine Sodium | 14 | $236 |
| Atorvastatin Calcium | 13 | $217 |
| Zolpidem Tartrate | 25 | $187 |
| Simvastatin | 14 | $168 |
| Rosuvastatin Calcium | 18 | $118 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $115 |
| Alprazolam | 28 | $98 |
| Azithromycin | 18 | $65 |
| Hydrochlorothiazide | 13 | $59 |
| Sertraline Hcl | 14 | $51 |
| Ciprofloxacin Hcl | 11 | $42 |
| Lisinopril | 17 | $25 |
Paid to pharmacies, not to this prescriber.
Other family in Clarksville
- Ariana ChaoLutherville$727K
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Meredith SagalHunt Valley$82K
- Sharon Dudley-BrownBel Air$67K
- Joy MaulikSalisbury$47K
- Kristin AttiogbeChevy Chase$42K
- Sametta SanyaoluFulton$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.